Inhibition of Human Immunodeficiency Virus Type 1 Entry in Cells Expressing gp41-Derived Peptides

As the limitations of antiretroviral drug therapy, such as toxicity and resistance, become evident, interest in alternative therapeutic approaches for human immunodeficiency virus (HIV) infection is growing. We developed the first gene therapeutic strategy targeting entry of a broad range of HIV typ...

תיאור מלא

מידע ביבליוגרפי

הוצא לאור ב:	J Virol
Principais autores:	Egelhofer, Marc, Brandenburg, Gunda, Martinius, Holger, Schult-Dietrich, Patricia, Melikyan, Gregory, Kunert, Renate, Baum, Christopher, Choi, Ingrid, Alexandrov, Alexander, von Laer, Dorothee
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Microbiology (ASM) 2004
נושאים:	Vaccines and Antiviral Agents
גישה מקוונת:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC368739/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14694088/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.2.568-575.2004
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!